Skip to main content

Table 5 Correlations between IOCv2 dimensions and sociodemographic and treatment characteristics and mean scores of IOCv2 dimensions

From: Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population

    Chemotherapy Radiotherapy Surgery Hormonotherapy Partnered
  Time since diagnosis Age No Yes No Yes No Yes No Yes No Yes
N = 64 N = 142 N = 11 N = 218 N = 6 N = 219 N = 60 N = 146 N = 58 N = 183
Positive impact dimensions
SS −0.05 −0.13* 3.28 3.43 3.65 3.37 3.42 3.39 3.40 3.42 3.37 3.47
AE 0.01 −0.08 3.56 3.73 3.68 3.68 3.63 3.70 3.72 3.71 3.71 3.68
HA −0.08 −0.17* 3.75 3.86 4.00 3.80 4.00 3.81 3.80 3.88 3.87 3.80
MOC 0.01 −0.02 2.74 2.90 3.45* 2.83* 2.77 2.86 2.89 2.91 2.99 2.84
PSE −0.08 −0.11 3.21 3.38 3.52 3.32 3.50 3.34 3.36 3.32 3.42 3.31
Negative impact dimensions
SS −0.04 −0.04 2.70 2.92 2.66 2.85 3.12 2.85 2.77 2.91 2.85 2.91
AC −0.03 −0.12 2.44* 2.85* 2.73 2.70 2.93 2.71 2.42* 2.82* 2.70 2.78
BCC −0.05 −0.01 2.93 3.18 2.61 3.08 3.17 3.08 2.9 3.18 3.05 3.09
LI −0.01 0.00 2.30 2.47 2.17 2.43 2.71 2.42 2.39 2.47 2.54 2.38
W −0.04 −0.03 3.11 3.31 3.14 3.25 3.54 3.25 3.25 3.29 3.31 3.25
    N = 28 N = 73 N = 5 N = 100 N = 3 N = 101 N = 27 N = 71 N = 79 N = 27
EC −0.06 0.07 2.21 2.48 2.27 2.43 2.56 2.42 2.53 2.34 2.40 2.44
    N = 11 N = 40 N = 2 N = 53 N = 1 N = 53 N = 10 N = 42   
NP −0.14 0.03 2.33 2.75 2.50 2.63 NA NA 3.33* 2.42*   
    N = 51 N = 95 N = 9 N = 155 N = 4 N = 158 N = 45 N = 103   
P 0.13 0.19* 1.77 1.78 1.33* 1.82* 2.38 1.77 1.63 1.85   
  1. * p value of the t test < 0.05
  2. NA: not applicable